Alpha-blockers specifically reduce nocturia episodes in men with diabetes with BPH [45] while improving peripheral insulin sensitivity and attenuating orthostatic hypotension in diabetic autonomic neuropathy [46], potentially explaining the enhanced protective effect observed. This evidence concerns the gene INS and diabetic autonomic neuropathy.